Advertise | About Us | Contact Us

- Issue 63

AI and Computational Modeling Approaches for Dose Optimisation During Drug Development

Article - Issue 63

Artificial Intelligence (AI) - From promise to practice

Article - Issue 63

Beyond Perfect Patients

Article - Issue 63

Reimagining Pharmacovigilance

Article - Issue 63

Beyond Trial and Error

EDITORIAL SECTIONS

Why X-ray Inspection is a Viable Quality Assurance Solution for Pharma Products

Adopting the Power of AI to Drug Development Projects

A tremendous amount of documentation is created throughout the clinical trial lifecycle

Real-world Evidence

Hearing the diagnosis from the doctor that your child has spinal muscular atrophy SMA

Just in Time Manufacturing Creating more sustainable supply chains

Drug development has transformed immeasurably over the past decade Even before the Covid pandemic and the conflict in Ukraine

Challenges and Advantages of Using Artificial Intelligence in Pharma

Many advanced largescale AI initiatives still need to be proved successful in Pharma

Advisory Board

Victor M. Diaz Perez

Brian D Smith

Nigel Cryer FRSC

Quang Bui

Tamara Miller

Imedla Leslie Rillon

Andri Kusandri

Nicoleta Grecu

Alessio Piccoli

Pramod Kashid

Neil J Campbell

Tendering Manager Asia-Pacific
Powder Systems Limited PSL has been exporting its technology to the AsiaPacific market since and a growing number of turnkey installations are to be commissioned in this region in the future To support the demand PSL has committed to further investment in AsiaPacific APAC by opening an engineering and sales office in Singapore This addition to PSL APAC will reinforce the fast growing activities c...

Articles

The Green Revolution in Medicine

The term Green Revolution originally referred to the agricultural transformation of the s when scientific advances dramatically increased food production and reshaped global food security That revolution changed the world by solving a critical human challenge hunger Yet today humanity faces a new crisis that is equally

Research Insights

Mapping Metabolic Reprogramming in Lung and Breast Cancer Through Integrative Bioinformatics

Metabolic reprogramming is central to cancer biology enabling tumor cells to sustain rapid proliferation resist stress and adapt to therapy However these alterations are highly heterogeneous across cancer types

Case Studies

Effects Of Particle Size On The Triboelectrification Phenomenon In Pharmaceutical Excipients: An Experimental Case Study

Abstract Particle sizes play a major role to mediate charge transfer both between identical and different material surfaces The study probes in to the probable mechanism that actuates opposite polarities between two different size fractions of the same material by analyzing the charge transfer patterns of two different sizes of MCC Quantum scale calculations

Techno Trends

Jacobio Pharma Introduces Novel KRAS G12C Inhibitor Glecirasib for Pancreatic Cancer

Jacobio Pharma has introduced an innovative inhouse solution with the KRAS GC inhibitor Glecirasib aimed at treating patients with pancreatic cancer

White Papers

Cloud Computing in the Laboratory Informatics Solutions and Validation Approaches

In the modern business environment, a significant portion of work is conducted using computerized systems. Many solutions are used to complete tasks, including simple desktop programs like email and Microsoft Office to enterprise-wide, global systems like ERP (Enterprise Resource Planning), MES (Manufacturing Execution System), and LIMS

Applying Human Factors Engineering to Generic Combination Products

Frauke Schuurkamp

Frauke Schuurkamp has 12 years of experience delivering HFE services to the medical and pharmaceutical industries. Schuurkamp conducts HFE workshops, advises on HFE strategies, leads research and analysis activities and develops key deliverables to support FDA and international regulatory submissions. Schuurkamp holds a bachelor’s degree in applied psychology and a master’s degree in human factors psychology.

Lisanne de Vogel

Lisanne de Vogel has 7+ years of experience delivering HFE services to the medical device and pharmaceutical industries. Lisanne leads and oversees human factors research activities, such as usability testing, and helps clients develop key HFE documents for their (international) regulatory submissions, as well as advising them on how to apply HFE during product development to meet regulators' expectations. She holds a bachelor’s degree in Communication Science and a master’s degree in Applied Cognitive Psychology.

Decoding Antisense Oligonucleotides: Mechanisms, Applications, and Future Directions

Dr. Arun Shastry

Dr. Arun Shastry is a Bengaluru-based scientist with a PhD in Immunogenetics. He is the Co-Founder, Managing Director, and Chief Scientific Officer (CSO) of Hanugen Therapeutics, a pioneering biopharmaceutical company focused on oligonucleotide-based therapies for rare genetic diseases, particularly Duchenne Muscular Dystrophy (DMD). With over two decades in drug discovery for rare disorders, Dr. Shastry drives affordable, accessible treatments through innovative personalized medicine approaches in India.

Advanced Nanobots for ‘Programmed’ Biomedical Applications

Amaresh Kumar Sahoo

Assistant Professor, Department of Applied Sciences, Indian Institute of Information Technology

Saurabh Shivalkar

Research Fellow, Department of Applied Sciences, Indian Institute of Information Technology

Revolutionising Drug Discovery and Development with Artificial Intelligence

Aarti Chitale

13+ years of healthcare and life sciences industry experience in growth consulting and market intelligence. Aarti Chitale has a strong understanding of pharma and biopharma industry especially the Technology enabled Drug Discovery and Development and Contract Pharma services Industry with keen interest in Emerging Business Models and new growth avenues.

Redefining Therapeutics

Mads Hald Andersen

Professor Mads Hald Andersen, DMSc, DScTech, PhD, is Director of the National Center for Cancer Immune Therapy, CCIT-DK, at Copenhagen University Hospital Herlev, Denmark. He discovered tumor microenvironment antigens and anti-regulatory T cells and defined their role in immune regulation. He initiated the immune modulatory vaccine concept and has authored more than 250 publications and 25 patents.

INDUSTRY UPDATES

press releasesRead more...

Innovent Biologics announced a strategic collaboration with Eli Lilly on research and development and licensing.

Innovent Biologics SSE HKSE a hightech biopharmaceutical company today announced a strategic collaboration agreement with Eli Lilly and Company for research and licensing focusing on the development of innovative drugs

Cellares and Seoul National University Hospital Launch Proof-of-Concept for Automated Manufacturing of Gene-Modified HSPC Therapy on the Cell Shuttle® Platform

Cellares the first Integrated Development and Manufacturing Organization IDMO and Seoul National University Hospital SNUH a leading translational medical center in South Korea today announced a partnership

Zymeworks Completes Acquisition of Theravance Biopharma

Zymeworks Inc Nasdaq ZYME a biotechnology company managing a portfolio of licensed healthcare assets while developing a diverse pipeline of novel multifunctional biotherapeutics today completed

UofG announces second research collaboration with Eli Lilly and Company for immune-related diseases

Worldchanging experts at the University of Glasgow will partner with scientists at leading pharmaceutical company Eli Lilly and Company Lilly to tackle immunerelated diseases

Thermo Fisher Scientific Launches Gibco™ CHO-K1 Catalog Panel Media and Feed to Accelerate Biologics Development

Thermo Fisher Scientific the world leader in serving science today announced the Gibco CHOK Catalog Panel a cGMPready portfolio of basal and feed media designed to support strong

Oracle Partners with Wipro to Strengthen End-to-End Pharmacovigilance Services

Oracle Life Sciences announced a partnership with Wipro Limited a leading AIpowered technology services and consulting company to strengthen Wipros pharmacovigilance PV service offering using Oracle Life